Israel Englander’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.73M | Sell |
51,600
-43,200
| -46% | -$3.78M | ﹤0.01% | 3040 |
|
|
2026
Q1 | $8.08M | Sell |
94,800
-77,900
| -45% | -$6.94M | ﹤0.01% | 2389 |
|
|
2025
Q4 | $13.6M | Buy |
172,700
+71,500
| +71% | +$5.61M | 0.01% | 1939 |
|
|
2025
Q3 | $8.09M | Sell |
101,200
-12,300
| -11% | -$1.05M | ﹤0.01% | 2610 |
|
|
2025
Q2 | $10.3M | Sell |
113,500
-23,300
| -17% | -$2.13M | 0.01% | 2220 |
|
|
2025
Q1 | $12.8M | Sell |
136,800
-80,100
| -37% | -$7.17M | 0.01% | 1930 |
|
|
2024
Q4 | $19.7M | Buy |
216,900
+80,800
| +59% | +$7.71M | 0.01% | 1529 |
|
|
2024
Q3 | $14.1M | Sell |
136,100
-101,700
| -43% | -$10.4M | 0.01% | 1869 |
|
|
2024
Q2 | $23.1M | Buy |
237,800
+219,600
| +1,207% | +$20.3M | 0.01% | 1372 |
|
|
2024
Q1 | $1.64M | Sell |
18,200
-13,400
| -42% | -$1.14M | ﹤0.01% | 3903 |
|
|
2023
Q4 | $2.52M | Buy |
31,600
+6,800
| +27% | +$511K | ﹤0.01% | 3409 |
|
|
2023
Q3 | $1.76M | Sell |
24,800
-19,700
| -44% | -$1.47M | ﹤0.01% | 3678 |
|
|
2023
Q2 | $3.43M | Sell |
44,500
-17,800
| -29% | -$1.38M | ﹤0.01% | 3012 |
|
|
2023
Q1 | $4.68M | Buy |
62,300
+25,600
| +70% | +$1.9M | ﹤0.01% | 2662 |
|
|
2022
Q4 | $2.89M | Sell |
36,700
-442,100
| -92% | -$33.1M | ﹤0.01% | 3245 |
|
|
2022
Q3 | $33.6M | Buy |
+478,800
| New | +$37.5M | 0.02% | 935 |
|
|
2021
Q2 | – | Sell |
-5,600
| Closed | -$441K | – | 6571 |
|
|
2021
Q1 | $441K | Sell |
5,600
-900
| -14% | -$70.5K | ﹤0.01% | 4918 |
|
|
2020
Q4 | $556K | Sell |
6,500
-12,400
| -66% | -$1.03M | ﹤0.01% | 4113 |
|
|
2020
Q3 | $1.46K | Sell |
18,900
-51,700
| -73% | -$3.94M | ﹤0.01% | 2849 |
|
|
2020
Q2 | $5.17M | Buy |
+70,600
| New | +$5.02M | 0.01% | 1733 |
|
|
2019
Q3 | – | Sell |
-3,400
| Closed | -$244K | – | 4209 |
|
|
2019
Q2 | $244K | Sell |
3,400
-1,200
| -26% | -$85.2K | ﹤0.01% | 3656 |
|
|
2019
Q1 | $315K | Buy |
+4,600
| New | +$297K | ﹤0.01% | 3523 |
|
|
2018
Q4 | – | Sell |
-350,000
| Closed | -$23.4M | – | 3789 |
|
|
2018
Q3 | $23.4M | Buy |
350,000
+250,000
| +250% | +$16.7M | 0.03% | 757 |
|
|
2018
Q2 | $6.48M | Sell |
100,000
-365,000
| -78% | -$23.9M | 0.01% | 1626 |
|
|
2018
Q1 | $33.3M | Buy |
465,000
+395,000
| +564% | +$28.4M | 0.04% | 615 |
|
|
2017
Q4 | $5.28M | Sell |
70,000
-130,000
| -65% | -$9.49M | 0.01% | 1717 |
|
|
2017
Q3 | $14.6M | Sell |
200,000
-225,000
| -53% | -$16.2M | 0.02% | 977 |
|
|
2017
Q2 | $31.5M | Buy |
+425,000
| New | +$31.6M | 0.06% | 491 |
|
|
2016
Q2 | – | Sell |
-135,000
| Closed | -$9.54M | – | 3202 |
|
|
2016
Q1 | $9.54M | Buy |
+135,000
| New | +$8.98M | 0.02% | 864 |
|
|
2014
Q4 | – | Sell |
-6,200
| Closed | -$404K | – | 3941 |
|
|
2014
Q3 | $404K | Buy |
+6,200
| New | +$409K | ﹤0.01% | 2868 |
|
Other funds holding CL
Israel Englander's CL Position: Q2 2026 in Review
Israel Englander increased its Colgate-Palmolive (CL) stake by 72% in Q2 2026, buying an estimated $46.8M and bringing the position to 1,276,446 shares worth $117M. The position accounts for 0.04% of the portfolio, ranked #446.
Israel Englander first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $496M in Q4 2023. 2,007 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Israel Englander held 1,276,446 shares of Colgate-Palmolive worth $117M as of Q2 2026.
- Israel Englander bought 535,326 Colgate-Palmolive shares in Q2 2026, an estimated $46.8M.
- Colgate-Palmolive made up 0.04% of Israel Englander's portfolio in Q2 2026, its #446 holding.
- Israel Englander first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
- Israel Englander's Colgate-Palmolive position peaked at $496M in Q4 2023.
- 2,007 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.